Shortage reports
Actual shortage:
259 (8%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3057 (92%)
3327
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
11 (4%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2022-01-20 | 2022-06-16 | 153189 |
| TEVA-VALSARTAN | 160MG | TABLET | Resolved | 2021-04-22 | 2023-06-09 | 137936 |
| TEVA-VALSARTAN | 160MG | TABLET | Actual shortage | 2025-02-06 | 2025-11-20 | 249728 |
| TEVA-VALSARTAN | 80MG | TABLET | Actual shortage | 2025-09-04 | 2026-04-09 | 266631 |
| TEVA-VALSARTAN | 40MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137930 |
| TEVA-VALSARTAN | 80MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137933 |
| TEVA-VALSARTAN | 320MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137939 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-09-26 | 2025-04-25 | 94834 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Resolved | 2017-03-13 | 2018-05-11 | 1226 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1552 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2020-01-24 | 2025-04-25 | 104333 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Resolved | 2018-10-23 | 2025-04-25 | 65375 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Resolved | 2017-04-25 | 2018-02-21 | 8074 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Resolved | 2018-10-23 | 2025-04-25 | 65372 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Resolved | 2018-10-23 | 2025-04-29 | 65369 |
| TEVA-VARENICLINE | 0.5MG | TABLET | Actual shortage | 2021-02-05 | 2021-02-05 | 133473 |
| TEVA-VARENICLINE | 1MG | TABLET | Resolved | 2020-01-09 | 2020-06-11 | 102926 |
| TEVA-VARENICLINE | 1MG | TABLET | Resolved | 2019-08-22 | 2019-10-04 | 92206 |
| TEVA-VARENICLINE | 0.5MG 1MG | TABLET | Resolved | 2019-10-24 | 2020-06-11 | 97159 |
| TEVA-VARENICLINE | 1MG | TABLET | Resolved | 2020-07-14 | 2020-08-04 | 120262 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 4G 0.5G | POWDER FOR SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258717 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-12 | 2018-10-12 | 63943 |
| RATIO-FENOFIBRATE MC | 200MG | CAPSULE | Discontinued | 2018-10-19 | 2018-10-19 | 64891 |
| RATIO-LENOLTEC NO 1 | 300MG 8MG 15MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81362 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
| RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
| RATIO-TAMSULOSIN | 0.4MG | CAPSULE (SUSTAINED-RELEASE) | Discontinued | 2018-10-19 | 2018-10-19 | 64917 |
| RATIO-TOPISALIC | 0.5MG 20MG | LOTION | Discontinued | 2026-03-13 | 2026-03-13 | 280453 |